The Department of Stem Cell Science and Technology Development, Vice-Chancellor of Science and Technology, has announced the submission of papers to the 3rd International Congress on Stem Cell and Medical Technologies Reformed on September 15, 1397.

According to the Information Center for the Vice-Presidency of Science and Technology, The Department of Science and Technology Development of Stem Cells in cooperation with the universities of the country in order to promote the knowledge of the professors "Third National Festival and International Congress on Rehabilitated Medicine and Stem Cells Sciences and Technologies" Held at the Hall of the Summit with the valuable presence of all the activists of this field, including managers and decision-makers, professors, students, researchers, knowledge-based companies, manufacturers of pharmaceutical and medical equipment, Iranian researchers residing abroad, international scholars and scientists, and other interested in this strategic knowledge. The international congressional section of the festival, which will host the audience from December 28^th to November 1st, will be based on 12 main axes including: Applied Technologies for Stem Cell Research, Immune Cell Therapy, Gene Therapy and Gene Editing, Organoids in Disease Modeling and Development, Pluripotency and Reprogramming, Biomaterials and Devices, Tissue Engineering, Cell Banking, Cell Signalling and Cell-Derived Vesicles, Clinical Trials and Regenerative Medicine Interventions, Commercialization of Cell-Based and Regenerative Products, and Ethical, Legal and Social Issues.

In addition, as part of the international festival and Congress, "The first Iranian-French hematopoietic stem cell transplant symposium: New treatments for treating a host-related transplant (GvHD)" will be held at the venue of the Summit from December 28^th and researchers can post their research papers on GvHD disease through the website of the festival (http://stemcellfestival.com/Default.aspx?PN=269).

Submission of papers for the International Congress and the Symposium of Transplant Disease against the host, will end on September 6, 2018.